Press Releases

An analysis released today by the Centers for Disease Control and Prevention (CDC) showed that Alzheimer’s deaths have increased by 55 percent from 1999-2014, a disturbing progression of a disease that has no cure. The findings accentuate the critical need for actions that improve rates of early diagnosis, enhance support for caregivers, address growing racial disparities, and increase funding for research at the National Institutes of Health (NIH).  

The Administration’s FY 2018 budget request, calling for damaging decreases in  funding at the National Institutes of Health (NIH), is a potentially crushing blow for the 5.5 million Americans with Alzheimer’s and related dementias, and their caregivers, who are desperate for a cure.

UsAgainstAlzheimer’s strongly rejects any loss in funding levels for Alzheimer’s research and calls on Congressional leaders to continue to aggressively champion much-needed progress against this disease that will triple in the coming decades and currently costs the nation more than $250 billion annually. 

Leading Alzheimer’s disease researchers and a prominent patient advocate today published an analysis, “Single Endpoint for New Drug Approvals for Alzheimer’s Disease,” urging the Food and Drug Administration (FDA) to clarify and modernize its current approach for approving new treatments for Alzheimer’s disease.

Dr. William A. Vega, executive director of the USC Edward R. Roybal Institute on Aging at the USC Suzanne Dworak-Peck School of Social Work, was officially announced as a new member of the UsAgainstAlzheimer’s (UsA2) Network Board of Directors, where he will apply his deep knowledge in the areas of population health, gerontology and minority health to advance the organization’s mission to cure Alzheimer’s, the third-leading cause of death In the United States.

A bipartisan agreement to increase Alzheimer’s funding by $400 million at the National Institutes of Health (NIH) for FY 2017, part of a total spending increase of $2 billion at NIH, is a major achievement.  Congressional leaders, bolstered by thousands of advocates, including patients, caregivers, family members and allies, have responded to the urgent need to find a cure for Alzheimer’s, which affects more than 5.5 million Americans. 


^ Back to Top